Skip to content

Effects of Intensive Upper and Lower Limbs Motor Control Therapy in Cerebral Palsy Children

Effects of Intensive Upper and Lower Limbs Motor Control Therapy in Cerebral Palsy Children

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03521427
Enrollment
10
Registered
2018-05-11
Start date
2017-07-14
Completion date
2018-02-03
Last updated
2018-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Keywords

Intensive Therapy, Cerebral Palsy

Brief summary

The aim of the study is to determine the effetiveness of the intensive upper and lower limbs therapy to improve the funtional outcomes and to minimize ther energetic spendings during funtional activities in Cerebral Palsy patients.

Detailed description

The aim of the study is to determine the effetiveness of the intensive upper and lower limbs therapy to improve the funtional outcomes and to minimize ther energetic spendings during funtional activities in Cerebral Palsy patients. Also to know paretns and caregivers perceptions.

Interventions

Ninety hours of intensive bimanual therapy

OTHERIntensive neurodevelopmental therapy

Ninety hours of intensive neurodevelopmental therapy

Sponsors

European University Spain
CollaboratorOTHER
University of Alcala
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Cerebral Palsy

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Arm Funtion6 monthsAssissting Hand Assessment Instrument (AHA)

Secondary

MeasureTime frameDescription
Funtional Activity6 monthsJebsen Taylor Hand Funtion Test
Perception of performance in everyday living6 monthsCanadian Occupational Performance Measure (COMP)

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026